Clinical Efficiency of Application of Intravenous Immunoglobulin in Pregnant Women with Intrauterine Infection

The problem of intrauterine infection (IUI) is still relevant today. Ineffective treatment of this pathology is associated with physiological decline of the immunity in these patients. We have proposed the additional use of intravenous immunoglobulin for the treatment of pregnant women with IUI. The...

Full description

Bibliographic Details
Main Authors: O.L. Ishchenko, I.P. Krokhmal, S.M. Serhiienko, I.O. Kovtoniuk
Format: Article
Language:English
Published: Zaslavsky O.Yu. 2016-02-01
Series:Aktualʹnaâ Infektologiâ
Subjects:
Online Access:http://ai.zaslavsky.com.ua/article/view/74533
_version_ 1818997589559738368
author O.L. Ishchenko
I.P. Krokhmal
S.M. Serhiienko
I.O. Kovtoniuk
author_facet O.L. Ishchenko
I.P. Krokhmal
S.M. Serhiienko
I.O. Kovtoniuk
author_sort O.L. Ishchenko
collection DOAJ
description The problem of intrauterine infection (IUI) is still relevant today. Ineffective treatment of this pathology is associated with physiological decline of the immunity in these patients. We have proposed the additional use of intravenous immunoglobulin for the treatment of pregnant women with IUI. There were examined 75 patients with IUI, which was diagnosed in the II trimester. The I group consisted of 40 individuals who received conventional treatment, the II group was formed from 35 women who additionally received intravenous immunoglobulin. On the background of IUI, pregnancy was characterized by an increased incidence of threatened miscarriage and premature labor, gestosis and placental dysfunction; during delivery, premature rupture of amniotic membrane and fetal distress were more common. These patients had placenta with both ultrasonic and histological signs of infection. Among newborns, there was a significant increase in the incidence of pathology associated with intrauterine infection. Additional use of intravenous immunoglobulin in the treatment of IUI during the II trimester of pregnancy in comparison with conventional therapy leads to a significant reduction in the incidence of both obstetric complications and perinatal pathology.
first_indexed 2024-12-20T21:48:02Z
format Article
id doaj.art-9a577a457f2548ceaee29934f1824f9d
institution Directory Open Access Journal
issn 2312-413X
2312-4148
language English
last_indexed 2024-12-20T21:48:02Z
publishDate 2016-02-01
publisher Zaslavsky O.Yu.
record_format Article
series Aktualʹnaâ Infektologiâ
spelling doaj.art-9a577a457f2548ceaee29934f1824f9d2022-12-21T19:25:38ZengZaslavsky O.Yu.Aktualʹnaâ Infektologiâ2312-413X2312-41482016-02-0141.10323710.22141/2312-413x.1.10.2016.7453374533Clinical Efficiency of Application of Intravenous Immunoglobulin in Pregnant Women with Intrauterine InfectionO.L. Ishchenko0I.P. Krokhmal1S.M. Serhiienko2I.O. Kovtoniuk3State Institution «Luhansk State Medical University», Luhansk, UkraineState Institution «Luhansk State Medical University», Luhansk, UkraineState Institution «Luhansk State Medical University», Luhansk, UkraineState Institution «Luhansk State Medical University», Luhansk, UkraineThe problem of intrauterine infection (IUI) is still relevant today. Ineffective treatment of this pathology is associated with physiological decline of the immunity in these patients. We have proposed the additional use of intravenous immunoglobulin for the treatment of pregnant women with IUI. There were examined 75 patients with IUI, which was diagnosed in the II trimester. The I group consisted of 40 individuals who received conventional treatment, the II group was formed from 35 women who additionally received intravenous immunoglobulin. On the background of IUI, pregnancy was characterized by an increased incidence of threatened miscarriage and premature labor, gestosis and placental dysfunction; during delivery, premature rupture of amniotic membrane and fetal distress were more common. These patients had placenta with both ultrasonic and histological signs of infection. Among newborns, there was a significant increase in the incidence of pathology associated with intrauterine infection. Additional use of intravenous immunoglobulin in the treatment of IUI during the II trimester of pregnancy in comparison with conventional therapy leads to a significant reduction in the incidence of both obstetric complications and perinatal pathology.http://ai.zaslavsky.com.ua/article/view/74533intravenous immunoglobulinintrauterine infectionpregnancy complicationsneonatal pathology
spellingShingle O.L. Ishchenko
I.P. Krokhmal
S.M. Serhiienko
I.O. Kovtoniuk
Clinical Efficiency of Application of Intravenous Immunoglobulin in Pregnant Women with Intrauterine Infection
Aktualʹnaâ Infektologiâ
intravenous immunoglobulin
intrauterine infection
pregnancy complications
neonatal pathology
title Clinical Efficiency of Application of Intravenous Immunoglobulin in Pregnant Women with Intrauterine Infection
title_full Clinical Efficiency of Application of Intravenous Immunoglobulin in Pregnant Women with Intrauterine Infection
title_fullStr Clinical Efficiency of Application of Intravenous Immunoglobulin in Pregnant Women with Intrauterine Infection
title_full_unstemmed Clinical Efficiency of Application of Intravenous Immunoglobulin in Pregnant Women with Intrauterine Infection
title_short Clinical Efficiency of Application of Intravenous Immunoglobulin in Pregnant Women with Intrauterine Infection
title_sort clinical efficiency of application of intravenous immunoglobulin in pregnant women with intrauterine infection
topic intravenous immunoglobulin
intrauterine infection
pregnancy complications
neonatal pathology
url http://ai.zaslavsky.com.ua/article/view/74533
work_keys_str_mv AT olishchenko clinicalefficiencyofapplicationofintravenousimmunoglobulininpregnantwomenwithintrauterineinfection
AT ipkrokhmal clinicalefficiencyofapplicationofintravenousimmunoglobulininpregnantwomenwithintrauterineinfection
AT smserhiienko clinicalefficiencyofapplicationofintravenousimmunoglobulininpregnantwomenwithintrauterineinfection
AT iokovtoniuk clinicalefficiencyofapplicationofintravenousimmunoglobulininpregnantwomenwithintrauterineinfection